{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T06:42:20Z","timestamp":1697352140923},"reference-count":14,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,8,10]],"date-time":"2009-08-10T00:00:00Z","timestamp":1249862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2009,10]]},"abstract":"<jats:p><jats:bold>Aim:\u2002<\/jats:bold> Because i.v. barbiturates such as thiopental carry the risk of apnea and laryngeal spasm in asthmatic patients, reducing the use of barbiturate in emergency situations is important. The purpose of the present study was therefore to investigate the prevalence of i.v. thiopental as a choice of sedation in behavioral emergency settings, we conducted a cross\u2010sectional multicenter study.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Psychiatric emergency departments of seven hospitals were studied during a 4\u2010month period. Patients with a score &gt;15 on the Excited Component of the Positive and Negative Syndrome Scale (PANSS\u2010EC) who received i.v. medication were included in the study. Drugs were chosen according to the Japanese guidelines, in which the first injection was either haloperidol or benzodiazepine in accordance with clinical requirements. A second injection, which was the opposite drug to the first injection was administered as needed. Only when excitement obviously increased following the first injection, which was considered uncontrollable without thiopental according to expert experience, was thiopental given as a second injection. A total of 137 patients were included. The mean age was 40.4\u2003years (SD 13.1), and the rate of male gender, drug\u2010na\u00efve, and F2 (schizophrenia, schizotypal and delusional disorders) on the ICD\u201010 were 48.9%, 29.9%, and 65.7%, respectively.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> The rate of patients treated with thiopental as a second injection was 8.0% (<jats:italic>n<\/jats:italic>\u2003=\u200311). All of the first injections in patients treated with thiopental were not haloperidol but benzodiazepines (<jats:italic>P<\/jats:italic>\u2003=\u20030.0072).<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> Because this multicenter study has an epidemiological character, the prevalence of i.v. thiopental use in psychiatric emergency settings in Japan is considered to be 8.0%.<\/jats:p>","DOI":"10.1111\/j.1440-1819.2009.02010.x","type":"journal-article","created":{"date-parts":[[2009,8,11]],"date-time":"2009-08-11T01:53:24Z","timestamp":1249955604000},"page":"658-662","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence of i.v. thiopental use in psychiatric emergency settings in Japan"],"prefix":"10.1111","volume":"63","author":[{"given":"Kotaro","family":"Hatta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Hamakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Wakejima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshitaka","family":"Kawabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyoaki","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chie","family":"Usui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,9,23]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200519090-00003"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2006.00870.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.1981.tb01693.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199505000-00004"},{"key":"e_1_2_6_6_2","first-page":"357","article-title":"Anaesthetic management in asthma","volume":"73","author":"Burburan SM","year":"2007","journal-title":"Minerva Anestesiol."},{"key":"e_1_2_6_7_2","first-page":"24","volume-title":"Guidelines for Psychiatric Emergency Treatment, version 2003","author":"Hatta K","year":"2003"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004060050036"},{"key":"e_1_2_6_9_2","volume-title":"Positive and Negative Syndrome Scale (PANSS) Rating Manual","author":"Key SR","year":"1991"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.5.441"},{"key":"e_1_2_6_11_2","volume-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy W","year":"1976"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.53.9.1077"},{"key":"e_1_2_6_13_2","volume-title":"Evaluation and Diagnosis of Drug\u2010Induced Extrapyramidal Symptoms: Commentary on the DIEPSS and Guide to Its Usage","author":"Inada T","year":"1996"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200111000-00019"},{"key":"e_1_2_6_15_2","article-title":"A prospective naturalistic multicenter study of intravenous medications in behavioral emergencies: Haloperidol versus flunitrazepam","author":"Hatta K","year":"2009","journal-title":"Psychiatry Res."}],"container-title":["Psychiatry and Clinical Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1819.2009.02010.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1819.2009.02010.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T11:15:47Z","timestamp":1697282147000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1819.2009.02010.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,23]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["10.1111\/j.1440-1819.2009.02010.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1819.2009.02010.x","archive":["Portico"],"relation":{},"ISSN":["1323-1316","1440-1819"],"issn-type":[{"value":"1323-1316","type":"print"},{"value":"1440-1819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,23]]}}}